Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

ClinicalTrials.gov ID: NCT01384292

Public ClinicalTrials.gov record NCT01384292. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Relieving Opioid-Induced Constipation (OIC) in Patients With Cancer-Related Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effect of NKTR-118 with placebo in the treatment of opioid-induced constipation (OIC) in patients with cancer-related pain, including those patients that have inadequate response to laxative therapy (LIR). The study consists of 2 parts; A initial 4-week treatment period (part A) and then a 12 week extension with active treatment (part B).

Study identification

NCT ID
NCT01384292
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
14 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2011 (Type not available)
Primary completion
Sep 2012 (Actual)
Completion
Sep 2012 (Actual)
Last update posted
Jun 1, 2015

2011 – 2012

United States locations

U.S. sites
81
U.S. states
31
U.S. cities
81
Facility City State ZIP Site status
Research Site Huntsville Alabama — —
Research Site Casa Grande Arizona — —
Research Site Phoenix Arizona — —
Research Site Tucson Arizona — —
Research Site Fort Smith Arkansas — —
Research Site Hot Springs Arkansas — —
Research Site North Little Rock Arkansas — —
Research Site Encino California — —
Research Site Fountain Valley California — —
Research Site Gilroy California — —
Research Site Laguna Hills California — —
Research Site Montebello California — —
Research Site Orange California — —
Research Site Riverside California — —
Research Site San Bernardino California — —
Research Site Aurora Colorado — —
Research Site Denver Colorado — —
Research Site Baypines Florida — —
Research Site Boynton Beach Florida — —
Research Site Celebration Florida — —
Research Site Clearwater Florida — —
Research Site Coral Gables Florida — —
Research Site Hialeah Florida — —
Research Site Jacksonville Florida — —
Research Site Lake Worth Florida — —
Research Site Lakeland Florida — —
Research Site Miami Florida — —
Research Site Miami Lakes Florida — —
Research Site Naples Florida — —
Research Site Plantation Florida — —
Research Site Tavares Florida — —
Research Site Albany Georgia — —
Research Site Marietta Georgia — —
Research Site Riverdale Georgia — —
Research Site Roswell Georgia — —
Research Site Honolulu Hawaii — —
Research Site Chicago Illinois — —
Research Site Springfield Illinois — —
Research Site Anderson Indiana — —
Research Site Evansville Indiana — —
Research Site Owensboro Kentucky — —
Research Site Lafayette Louisiana — —
Research Site Elkridge Maryland — —
Research Site Hollywood Maryland — —
Research Site Boston Massachusetts — —
Research Site Fairhaven Massachusetts — —
Research Site Detroit Michigan — —
Research Site Kalamazoo Michigan — —
Research Site Southaven Mississippi — —
Research Site Jefferson City Missouri — —
Research Site St Louis Missouri — —
Research Site Missoula Montana — —
Research Site Omaha Nebraska — —
Research Site Las Vegas Nevada — —
Research Site Toms River New Jersey — —
Research Site Voorhees Township New Jersey — —
Research Site Great Neck New York — —
Research Site Syracuse New York — —
Research Site Chapel Hill North Carolina — —
Research Site Flat Rock North Carolina — —
Research Site Morrisville North Carolina — —
Research Site Wilmington North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Bismarck North Dakota — —
Research Site Akron Ohio — —
Research Site Beavercreek Ohio — —
Research Site Cleveland Ohio — —
Research Site Middleton Ohio — —
Research Site Danville Pennsylvania — —
Research Site East Providence Rhode Island — —
Research Site Charleston South Carolina — —
Research Site Chattanooga Tennessee — —
Research Site Beaumont Texas — —
Research Site Bellaire Texas — —
Research Site Corpus Christi Texas — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site Lubbock Texas — —
Research Site San Antonio Texas — —
Research Site Sugarland Texas — —
Research Site Fairfax Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01384292, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01384292 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →